Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials
Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Olivia R Ghosh-Swaby, Shaun G Goodman, Lawrence A Leiter, Alice Cheng, Kim A Connelly, David Fitchett, Peter Jüni, Michael E Farkouh, Jacob A Udell
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Failure | Legislation